等待开盘 04-01 09:30:00 美东时间
+0.040
+0.10%
今日重点评级关注:HC Wainwright & Co.:维持BridgeBio Oncology"买入"评级,目标价从27美元升至29美元;韦德布什:维持WAVE Life Sciences"跑赢大市"评级,目标价从33美元升至35美元
03-09 11:47
DAWN周涨一倍,获国际制药集团Servier溢价收购;Ziff Davis周涨56.3%,将其下属部门出售给埃森哲,获巴克莱上调其目标价;TNGX周涨52.1%,Q4亏损同比收窄超预期>>
03-07 10:50
Citigroup analyst Ronald Josey maintains Ziff Davis (NASDAQ:ZD) with a Neutral and raises the price target from $29 to $48.
03-07 00:35
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
获埃森哲12亿美元收购旗下 Ookla,ZD暴涨超48%;Q4亏损收窄收入增长17%,普拉格能源大涨超23%>>
03-04 16:24
Ziff Davis, Inc. (NASDAQ: ZD) shares are up on Tuesday following the announcement of a definitive agreement to sell its Connectivity division to Accenture plc (NYSE: ACN) for $1.2 billion in cash.
03-04 01:29
今日重点评级关注:巴克莱:维持Vir Biotechnology"超配"评级,目标价从26美元升至30美元;巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从10美元升至11美元
02-26 09:30
UBS analyst Chris Kuntarich maintains Ziff Davis (NASDAQ:ZD) with a Neutral and lowers the price target from $38 to $30.
02-26 03:40
华盛资讯2月25日讯,Ziff Davis, Inc.公布2025财年年度业绩,公司年度营收14.51亿美元,同比增长3.5%,归母净利润0.47亿美元,同比下滑24.9%。
02-25 08:31
Ziff Davis shares are trading lower after the company reported worse-than-expec...
02-24 22:15